Filter Results:
(149)
Show Results For
- All HBS Web
(149)
- People (1)
- News (41)
- Research (57)
- Events (6)
- Multimedia (4)
- Faculty Publications (34)
Show Results For
- All HBS Web
(149)
- People (1)
- News (41)
- Research (57)
- Events (6)
- Multimedia (4)
- Faculty Publications (34)
- 28 Aug 2023
- Research & Ideas
The Clock Is Ticking: 3 Ways to Manage Your Time Better
biomedical research institute. We measured employees’ daily work locations using building-badge swipe data, as well as various work and work-life outcomes via biweekly surveys. We found that each employee’s individual outcomes—such as... View Details
Keywords: by Kristen Senz
- Web
Blavatnik Fellowship in Life Science Entrepreneurship - Health Care
closely with leading biotech industry and biomedical authorities, receive programmatic guidance and mentorship, and join a community of entrepreneurs shaping the future of science. “ Bringing life science innovations to the global... View Details
Amy W. Schulman
Amy W. Schulman joined Harvard Business School’s Faculty as a Senior Lecturer in July 2014.
In addition to her responsibilities at Harvard, Ms. Schulman is a managing partner at Polaris Partners, who focuses on investing in healthcare... View Details
- 2001
- Chapter
Publicly Funded Science and the Productivity of the Pharmaceutical Industry
By: Rebecca Henderson and Ian Cockburn
U.S. taxpayers funded $14.8 billion of health related research last year, four times the amount that was spent in 1970 in real terms. In this paper we evaluate the impact of these huge expenditures on the technological performance of the pharmaceutical industry. While... View Details
Keywords: Public Sector; Science-Based Business; Research and Development; Sovereign Finance; Pharmaceutical Industry
Henderson, Rebecca, and Ian Cockburn. "Publicly Funded Science and the Productivity of the Pharmaceutical Industry." In Innovation Policy and the Economy, Volume 1, edited by Adam B. Jaffe, Josh Lerner, and Scott Stern, 1–34. MIT Press, 2001.
- 11 Jun 2009
- Working Paper Summaries
Social Influence Given (Partially) Deliberate Matching: Career Imprints in the Creation of Academic Entrepreneurs
- 22 Apr 2009
- Working Paper Summaries
Where is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location
- 01 Dec 2023
- News
Joint Venture
recalls. The chemically engineered cartilage platform had enormous potential for patients with osteoarthritis—more than 650 million people suffer from the degenerative joint disorder worldwide—and other kinds of joint pain. Surakanti and cofounder Dimitrios Angelis... View Details
Keywords: Shoshi Parks
- 14 Mar 2014
- HBS Seminar
Jeremy M. Levin, former President and CEO, Teva Pharmaceutical Industries
- Web
Profiles - MBA
Find David on LinkedIn . AB Biomedical Engineering, AB Computer Science, SM Engineering Sciences QUINCY 2026 Cohort 7 Jason Cho “Imagine Reckless Miracles' is the motto of my startup, 01ab. We live in a world where technology, innovation,... View Details
- Web
HBS - The year in Review
work closely with leading biotech industry and biomedical authorities, receive programmatic guidance and mentorship, and join a community of entrepreneurs shaping the future of science. To date, the Blavatnik Fellows have created 35... View Details
- 29 Apr 2016
- HBS Seminar
Richard Freeman, Harvard University & NBER
- 22 Feb 2022
- Research & Ideas
Lack of Female Scientists Means Fewer Medical Treatments for Women
treatments that primarily benefit women, yet an examination of biomedical patents filed over a 30-year period revealed a significant shortage of inventions targeting women’s health versus the large volume of new products for male... View Details
Keywords: by Kristen Senz
- Web
For Alumni - Health Care
you an entrepreneur commercializing new biomedical technology? Then, build your venture in the Blavatnik Fellowship in Life Science Entrepreneurship. Since 2013, Blavatnik Fellows started 45 companies and collectively raised more than... View Details
- Web
Online Business Strategy Course | HBS Online
discussions was empowering. It ignited a drive within me to learn and absorb as much as I could. Leslie Pico A small business owner and tech entrepreneur from Arizona Programming & System Analysis, Biomedical Engineering, Estrella... View Details
- 28 Apr 2015
- Blog Post
3 Reasons Engineers Thrive at Business School
engineer (Guy Kamguia MBA 2015), a biomedical engineer (Miranda Shaw MBA 2015), and a design engineer (Carol Rego MBA 2016) to get their thoughts on engineers pursuing an MBA. So, why do engineers thrive at business school? They’re number... View Details
- 03 Dec 2021
- Blog Post
Physicians Off the Beaten Path
With their podcast, Alexey Youssef (MBA 2022) and Shad Faraz (MBA 2022) bust the myth that physicians cannot venture outside the traditional career path. In my first year of university, one of my professors hosted a special session on “how to talk like doctors.” I was... View Details
- Web
Organizational Leadership Course | HBS Online
owner and tech entrepreneur from Arizona Programming & System Analysis, Biomedical Engineering, Estrella Mountain Community College Small Business Administration, Northern Arizona University Getting the perspective of a problem from... View Details
- Web
Judges - Alumni
Siemens Medical in Pennsylvania. He obtained his Engineering degree at the Polytechnic University in Madrid, Spain; with specialization in Biomedical Engineering at the Technical University of Delft in the Netherlands. He also holds an... View Details
- 01 Dec 2013
- News
To Market, to Market
patients, too long. Announced earlier this year, a $50 million gift to Harvard University by the Blavatnik Family Foundation, headed by Len Blavatnik (MBA 1989), addresses that challenge head-on. Building on the University's 2007 View Details
- 25 Apr 2014
- News
Bringing a new funding model to the life sciences industry
Andrew Farquharson (MBA 1999) wants to change the landscape for biomedical financing. The cofounder of VentureHealth, an online funding platform based in Silicon Valley, Farquharson leverages deals with investors who want access to View Details